Medicare Enrolled

Dr. Dianne Cheung, M.D.

Endocrinology · Torrance, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3445 PACIFIC COAST HWY STE 100, Torrance, CA 90505
3105426333
In practice since 2009 (17 years)
NPI: 1417197062 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheung? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheung

Dr. Dianne Cheung is an endocrinology specialist in Torrance, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Cheung performed 15,499 Medicare services across 1,603 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cheung received a total of $4,737 from 9 pharmaceutical and/or device companies across 46 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheung is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 6% volume in CA $4,737 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,499
Medicare services
Top 6% in CA for endocrinology
1,603
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~912 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 12,480 $18 $93
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,718 $100 $858
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
301 $12 $124
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
295 $28 $202
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
237 $99 $672
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
107 $10 $62
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
84 $1 $13
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
69 $8 $25
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
64 $128 $1,085
Blood glucose level test
A test that measures the amount of sugar in your blood.
41 $4 $25
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
25 $119 $597
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
22 $144 $960
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
20 $18 $119
Ultrasound-guided fine needle aspiration biopsy, each additional growth
This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session.
12 $48 $277
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
12 $72 $297
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
12 $34 $135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,737
Total received (2019-2024)
Avg $1,184/year across 4 years
Top 29% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
9
Companies
46
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,029 (63.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,250 (26.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$458 (9.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,485
2023
$630
2022
$1,262
2019
$360

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eli Lilly and Company
$2,117
Corcept Therapeutics
$258
Novo Nordisk Inc
$110
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2019-2024) ›
Eli Lilly and Company
$2,117
Becton, Dickinson and Company
$1,250
Novo Nordisk Inc
$518
Corcept Therapeutics
$293
AstraZeneca Pharmaceuticals LP
$227
Dexcom, Inc.
$146
Horizon Therapeutics plc
$112
Shire North American Group Inc
$62
Lilly USA, LLC
$12
Top 3 companies account for 82.0% of all-time payments
Associated products mentioned in payments ›
BD Nano 2nd Gen Pen Needle · Dexcom G6 Transmitter · FARXIGA · Korlym · NATPARA (PARATHYROID HORMONE) · Ozempic · TEPEZZA · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Torrance?
Compare endocrinologists in the Torrance area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
235
Per 100K population
2.4
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cheung is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cheung experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Cheung performed 12,480 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheung receive payments from pharmaceutical companies?
Yes. Dr. Cheung received a total of $4,737 from 9 companies across 46 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheung's costs compare to other endocrinologists in Torrance?
Dr. Cheung's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →